Clonidine transdermal system is a Transdermal Patch in the Human Prescription Drug category. It is labeled and distributed by Actavis Pharma, Inc.. The primary component is Clonidine.
Product ID | 0591-3509_53becf7a-05d0-4050-a1f7-bfe1d1f21711 |
NDC | 0591-3509 |
Product Type | Human Prescription Drug |
Proprietary Name | Clonidine transdermal system |
Generic Name | Clonidine |
Dosage Form | Patch |
Route of Administration | TRANSDERMAL |
Marketing Start Date | 2014-05-06 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA090873 |
Labeler Name | Actavis Pharma, Inc. |
Substance Name | CLONIDINE |
Active Ingredient Strength | 0 mg/d |
Pharm Classes | Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 2014-05-06 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | ANDA |
Application Number | ANDA090873 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2014-12-03 |
Marketing Category | ANDA |
Application Number | ANDA090873 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2014-05-06 |
Ingredient | Strength |
---|---|
CLONIDINE | .2 mg/d |
SPL SET ID: | 99a59495-2a48-4276-bbe3-cdd55a45aba4 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0591-3508 | Clonidine transdermal system | Clonidine |
0591-3509 | Clonidine transdermal system | Clonidine |
0591-3510 | Clonidine transdermal system | Clonidine |
21695-567 | Catapres | clonidine |
0597-0031 | Catapres-TTS | clonidine |
0597-0032 | Catapres-TTS | clonidine |
0597-0033 | Catapres-TTS | clonidine |
0378-0871 | Clonidine | clonidine |
0378-0872 | Clonidine | clonidine |
0378-0873 | Clonidine | clonidine |
39822-2000 | Clonidine | Clonidine |
39822-2010 | Clonidine | Clonidine |
50742-247 | Clonidine | clonidine |